Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Interest Expense Nonoperating

2.8 / 5 stars · 68/120 Roast Me

ACCURAY INCORPORATED Interest Expense Nonoperating

ACCURAY INCORPORATED (ARAY) reported Interest Expense Nonoperating of $32.91 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.

Financial Statements › Expense Statement › Interest Expense

us-gaap:InterestExpenseNonoperating · last filed 2026-08-27

  • ACCURAY INCORPORATED interest expense nonoperating for the quarter ending 2026-06-30 was $8.70M, a 105.82% increase year-over-year.
  • ACCURAY INCORPORATED interest expense nonoperating for the quarter ending 2026-03-31 was $8.45M, a 192.25% increase year-over-year.
  • ACCURAY INCORPORATED interest expense nonoperating for the quarter ending 2025-12-31 was $7.71M, a 167.40% increase year-over-year.
  • ACCURAY INCORPORATED interest expense nonoperating for the quarter ending 2025-09-30 was $8.05M, a 172.49% increase year-over-year.
  • ACCURAY INCORPORATED interest expense nonoperating for fiscal 2026 was $32.91M, a 154.01% increase from fiscal 2025.
  • ACCURAY INCORPORATED interest expense nonoperating for fiscal 2025 was $12.95M, a 11.44% increase from fiscal 2024.
  • ACCURAY INCORPORATED interest expense nonoperating for fiscal 2024 was $11.62M.
Period endInterest Expense Nonoperating 3 monthInterest Expense Nonoperating 6 monthInterest Expense Nonoperating 9 monthInterest Expense Nonoperating 12 month
2026-06-30$8.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
$17.14M
derived: sum of 2 quarters · filed 2026-08-27
$24.85M
derived: sum of 3 quarters · filed 2026-08-27
$32.91M
10-K · filed 2026-08-27
2026-03-31$8.45M
10-Q · filed 2026-05-06
$16.16M
derived: sum of 2 quarters · filed 2026-05-06
$24.21M
10-Q · filed 2026-05-06
$28.43M
derived: sum of 4 quarters · filed 2026-08-27
2025-12-31$7.71M
10-Q · filed 2026-02-17
$15.76M
10-Q · filed 2026-02-17
$19.99M
derived: sum of 3 quarters · filed 2026-08-27
$22.88M
derived: sum of 4 quarters · filed 2026-08-27
2025-09-30$8.05M
10-Q/A · filed 2026-02-17
$12.28M
derived: sum of 2 quarters · filed 2026-08-27
$15.17M
derived: sum of 3 quarters · filed 2026-08-27
$18.05M
derived: sum of 4 quarters · filed 2026-08-27
2025-06-30$4.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
$7.12M
derived: sum of 2 quarters · filed 2026-08-27
$10.00M
derived: sum of 3 quarters · filed 2026-08-27
$12.95M
10-K · filed 2026-08-27
2025-03-31$2.89M
10-Q · filed 2026-05-06
$5.77M
derived: sum of 2 quarters · filed 2026-05-06
$8.73M
10-Q · filed 2026-05-06
2024-12-31$2.88M
10-Q · filed 2026-02-17
$5.84M
10-Q · filed 2026-02-17
2024-09-30$2.96M
10-Q/A · filed 2026-02-17
2024-06-30$11.62M
10-K/A · filed 2026-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10